In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Investigative Dermatology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/J.0022-202X.2003.22113.XPMID 14962089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Keratin 17: a useful marker in anti-psoriatic therapies

  2004cited by this paper
• In situ localization of interferons in psoriatic lesions

  2004cited by this paper
• Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor‐2 (IRF‐2)

  2003cited by this paper
• Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases.

  2002cited by this paper
• Regulatory Effect of IFN-κ, A Novel Type I IFN, On Cytokine Production by Cells of the Innate Immune System

  2002cited by this paper
• IRF family of transcription factors as regulators of host defense.

  2001cited by this paper
• A modified ex vivo skin organ culture system for functional studies

  2001cited by this paper
• Abrupt onset of diabetes during interferon‐alpha therapy in patients with chronic hepatitis C

  2001cited by this paper
• Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes*

  2001cited by this paper
• Autoimmune diseases.

  2001cited by this paper
• Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.

  2000cited by this paper
• CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling.

  2000cited by this paper
• Treatment of Plantar Hyperhidrosis with Dermojet Injections of Botulinum Toxin

  2000cited by this paper
• Psoriasis Associated with HCV and Exacerbated by Interferon Alpha: Complete Clearance with Acitretin during Interferon Alpha Treatment for Chronic Active Hepatitis

  2000cited by this paper
• Systemic Lupus Erythematosus After α-Interferon Therapy for Chronic Hepatitis C: A Case Report and Review of the Literature

  2000cited by this paper
• Response of keratinocytes from normal and psoriatic epidermis to interferon‐γ differs in the expression of zinc‐α2‐glycoprotein and cathepsin D

  2000cited by this paper
• CD8 (+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-α/β signaling

  2000cited by this paper
• Psoriatic keratinocytes show reduced IRF-1 and STAT-1alpha activation in response to gamma-IFN.

  1999cited by this paper
• Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.

  1999cited by this paper
• Psoriatic keratinocytes show reduced IRF‐1 and STAT‐1α activation in response to γ‐IFN

  1999cited by this paper
• IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.

  1999cited by this paper
• The immunologic and genetic basis of psoriasis.

  1999cited by this paper
• IL‐1β and IFN‐γ induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN‐γ up‐regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL‐1 production

  1999cited by this paper
• Immunomodulation and Therapeutic Effects of the Oral Use of Interferon-alpha: Mechanism of Action

  1999cited by this paper
• Positive feedback regulation of type I IFN genes by the IFN‐inducible transcription factor IRF‐7

  1998cited by this paper
• Controlling Acute Elevation of Plasma Fibrinogen with Ancrod

  1998cited by this paper
• The antipsoriatic dimethyl-fumarate suppresses interferon-gamma -induced ICAM-1 and HLA-DR expression on hyperproliferative keratinocytes. Quantification by a culture plate-directed APAAP-ELISA technique.

  1998cited by this paper
• Transgenic mice expressing IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss.

  1997cited by this paper
• Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C.

  1997cited by this paper
• Hepatitis C virus infection and autoimmunity.

  1997cited by this paper
• Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C

  1996cited by this paper
• Psoriasis and hepatitis C virus.

  1995cited by this paper
• Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma.

  1995cited by this paper
• Expression of MxA protein in inflammatory dermatoses.

  1995cited by this paper
• The effect of anti-CD4 monoclonal antibody treatment on immunopathological changes in psoriatic skin.

  1994cited by this paper
• IL‐1 ALPHA‐INDUCED EXPRESSION OF ICAM‐1 ON CULTURED HYPERPROLIFERATIVE KERATINOCYTES: SUPPRESSION BY ANTIPSORIATIC DIMETHYL‐FUMARATE

  1994cited by this paper
• The Type I Interferon System Is Locally Activated in Psoriatic Lesions

  1994cited by this paper
• Psoriasis exacerbation induced by interferon-alpha. Report of two cases.

  1993cited by this paper
• Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

  1993cited by this paper
• Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins

  1992cited by this paper
• Modulation of leucocyte adhesion molecules, a T‐cell chemotaxin (IL‐8) and a regulatory cytokine (TNF‐α) in allergic contact dermatitis (rhus dermatitis)

  1991cited by this paper
• Keratin 17: a useful marker in anti-psoriatic therapies.

  1991cited by this paper
• The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.

  1990cited by this paper
• Synergistic interaction between interferon‐alpha and interferon‐gamma through induced synthesis of one subunit of the transcription factor ISGF3.

  1990cited by this paper
• Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line

  1988cited by this paper

• The molecular mechanism of the adverse effects of the biological and small molecular drugs in the therapy of inflammatory skin diseases – psoriasis and atopic dermatitis

  2026cites this paper
• The cytokine-skin barrier axis in health and disease.

  2025cites this paper
• Metal allergy as a persistent factor for psoriasis.

  2025cites this paper
• Cytokines in psoriasis: From pathogenesis to targeted therapy.

  2024cites this paper
• 3,3′-Diindolylmethane inhibits Th17 cell differentiation via impairing IRF-7-mediated plasmacytoid dendritic cell activation in imiquimod-induced psoriasis mice

  2024cites this paper
• Bimekizumab for the treatment of psoriasis.

  2024cites this paper
• Formononetin attenuates psoriasiform inflammation by regulating interferon signaling pathway.

  2024cites this paper
• A BET inhibitor, NHWD-870, can downregulate dendritic cells maturation via the IRF7-mediated signaling pathway to ameliorate imiquimod-induced psoriasis-like murine skin inflammation.

  2024cites this paper
• The multiple roles of interferon regulatory factor family in health and disease

  2024cites this paper
• The transcription regulators ZNF750 and LSD1/KDM1A dampen inflammation on the skin's surface by silencing pattern recognition receptors.

  2024cites this paper
• The role and application of three IFN-related reactions in psoriasis.

  2023cites this paper
• Type-I interferon pathway and DNA damage accumulation in peripheral blood of patients with psoriatic arthritis

  2023cites this paper
• The IFIH1/MDA5 rs1990760 Gene Variant (946Thr) Differentiates Early- vs. Late-Onset Skin Disease and Increases the Risk of Arthritis in a Spanish Cohort of Psoriasis

  2023cites this paper
• Deucravacitinib, a selective tyrosine kinase 2 inhibitor, for the treatment of moderate-to-severe plaque psoriasis

  2023cites this paper
• OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augment Type I Interferon-Induced JAK1-STAT1 Phosphorylation in Psoriasis.

  2022cites this paper
• Update on the etiopathogenesis of psoriasis (Review)

  2022cites this paper
• Transplantation of human adipose-derived stem cells overexpressing LIF/IFN-β promotes recovery in experimental autoimmune encephalomyelitis (EAE)

  2022cites this paper
• Gene Profiling of a 3D Psoriatic Skin Model Enriched in T Cells: Downregulation of PTPRM Promotes Keratinocyte Proliferation through Excessive ERK1/2 Signaling

  2022cites this paper
• Cytokine induced 3‐D organotypic psoriasis skin model demonstrates distinct roles for NF‐κB and JAK pathways in disease pathophysiology

  2022cites this paper
• Regulation of IL-17A-Producing Cells in Skin Inflammatory Disorders.

  2021cites this paper
• Janus Kinase Inhibitors in Dermatology: Part 2: Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses.

  2021cites this paper
• TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis.

  2021cites this paper
• Janus Kinase Inhibitors in Dermatology: Part 2 - Applications in Psoriasis, Atopic Dermatitis, and Other Dermatoses.

  2021cites this paper
• Anti-Psoriatic Effects of Antimony Compounds In Vitro

  2021cites this paper
• Type I interferon supports γδ T‐cell homeostasis and immunity through direct and indirect receptor signaling in mice

  2021cites this paper
• Interferon Kappa Is a Rheostat for Development of Psoriasiform Inflammation.

  2021cites this paper
• JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors

  2020cites this paper
• The role of cutaneous type I interferons in autoimmune and autoinflammatory diseases

  2020cites this paper
• The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases

  2020cites this paper
• The role of Th17 cells in psoriasis

  2020cites this paper
• Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate.

  2020cites this paper
• Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis

  2020cites this paper
• Innate Lymphocyte Mechanisms in Skin Diseases.

  2020cites this paper
• Controlling the rate of change of Ni dispersion in commercial catalyst by ALD overcoat during dry reforming of methane

  2020cites this paper
• The influence of interferon on healthy and diseased skin.

  2020cites this paper
• Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis

  2019cites this paper
• Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psoriasis-Associated Cytokines in vivo

  2019cites this paper
• CCID_A_218243 865..873

  2019cites this paper
• Protein biomarker for psoriasis: A systematic review on their role in the pathomechanism, diagnosis, potential targets and treatment of psoriasis.

  2018cites this paper
• Report of the inaugural Interferon Research Summit: interferon in inflammatory diseases

  2018cites this paper
• Serum cytokine measurements and biological therapy of psoriasis – Prospects for personalized treatment?

  2018cites this paper
• TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

  2018cites this paper
• Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis

  2018cites this paper
• Tofacitinib: A New Oral Therapy for Psoriasis

  2018cites this paper
• ASSOCIATION OF MEAN PLATELET VOLUME WITH DISEASE SEVERITY OF PSORIASIS VULGARIS

  2018cites this paper
• An Anti-Inflammatory Azaphenothiazine Inhibits Interferon β Expression and CXCL10 Production in KERTr Cells

  2018cites this paper
• IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasis.

  2017cites this paper
• STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes

  2017cites this paper
• Interferon- β exacerbates Th17 inflammatory diseases Relapse-remitting multiple sclerosis (RRMS) Interferon-

  2017cites this paper
• Análisis de supervivencia de terapia biológica en pacientes con psoriasis moderada-grave

  2017cites this paper
• Using siRNA‐based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis

  2017cites this paper
• Type I interferon pathway activation in COPA syndrome.

  2017cites this paper
• Differential regulation of surface receptor expression, proliferation, and apoptosis in HaCaT cells stimulated with interferon-γ, interleukin-4, tumor necrosis factor-α, or muramyl dipeptide

  2017cites this paper
• The Molecular Revolution in Cutaneous Biology: The Era of Global Transcriptional Analysis.

  2017cites this paper
• Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury.

  2016cites this paper
• Psoriasis Induced by Anti-Tumor Necrosis Factor Alpha Agents: A Comprehensive Review of the Literature.

  2016cites this paper
• Association of psoriasis and psoriatic arthritis with systemic lupus erythematosus

  2016cites this paper
• Tofacitinib for the treatment of psoriasis

  2016cites this paper
• IFN-β differentially regulates the function of T cell subsets in MS and EAE.

  2016cites this paper
• Abnormalities in the psoriatic non-lesional skin

  2016cites this paper
• Type I Interferons

  2016cites this paper
• SRSF1 Facilitates Cytosolic DNA-Induced Production of Type I Interferons Recognized by RIG-I

  2015cites this paper
• An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17.

  2015cites this paper
• Potential serum biomarkers of treatment response to ustekinumab in patients with psoriasis: a pilot study

  2015cites this paper
• Update on psoriasis immunopathogenesis and targeted immunotherapy

  2015cites this paper
• Translating nucleic acid-sensing pathways into therapies

  2015cites this paper
• The immunogenetics of Psoriasis: A comprehensive review.

  2015cites this paper
• Skin Inflammation Epidermal Autoantigen Induce Psoriasis-like Th17 Cells Carrying TCR Recognizing

  2013cites this paper
• Induction and exacerbation of psoriasis with Interferon‐alpha therapy for hepatitis C: A review and analysis of 36 cases

  2013cites this paper
• Modulation of Epidermal Transcription Circuits in Psoriasis: New Links between Inflammation and Hyperproliferation

  2013cites this paper
• Roles of Sema4A in multiple sclerosis and interferon‐β therapy efficacy

  2013cites this paper
• Psoriasis: Molecular targets of denervation and therapy

  2013cites this paper
• Pharmakologie von Interferon beta-1b

  2013cites this paper
• Psoriatic skin lesions induced by tumor-necrosis-factor-alpha-therapy *

  2013cites this paper
• Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity

  2013cites this paper
• Th17 Cells Carrying TCR Recognizing Epidermal Autoantigen Induce Psoriasis-like Skin Inflammation

  2013cites this paper
• STAT1 expression and activation is increased in lesional psoriatic skin

  2013cites this paper
• Janus‐like effects of type I interferon in autoimmune diseases

  2012cites this paper
• Cells: Implication for Psoriasis Potent Stimulators of Plasmacytoid Dendritic Inhibitor-Competent DNA Deposits Are Secretory Leukocyte Proteinase

  2012cites this paper
• Interferon Response Factors 3 and 7 Protect against Chikungunya Virus Hemorrhagic Fever and Shock

  2012cites this paper
• Janus kinase inhibition as a potential strategy for the treatment of psoriasis: state of the art and future perspectives.

  2012cites this paper
• Antimicrobial peptides in the pathogenesis of psoriasis

  2012cites this paper
• Secretory Leukocyte Proteinase Inhibitor-Competent DNA Deposits Are Potent Stimulators of Plasmacytoid Dendritic Cells: Implication for Psoriasis

  2012cites this paper
• Interferon-β exacerbates Th17-mediated inflammatory disease.

  2011cites this paper
• Role of the immune system and immunological circuits in psoriasis.

  2011cites this paper
• Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.

  2011cites this paper
• Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis.

  2011cites this paper
• Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism

  2011cites this paper
• Narrowband ultraviolet B inhibits innate cytosolic double‐stranded RNA receptors in psoriatic skin and keratinocytes

  2011cites this paper
• IL-23/IL-17 Axis Inflammation in Mice Is Mediated via the Imiquimod-Induced Psoriasis-Like Skin

  2011cites this paper
• Deficient SOCS3 and SHP-1 expression in psoriatic T cells.

  2010cites this paper
• Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis.

  2010cites this paper
• [The role of dendritic cells in auto-inflammation seen in psoriasis].

  2010cites this paper
• L'auto-inflammation dans le psoriasis: rôle des cellules dendritiques

  2010cites this paper
• A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis.

  2010cites this paper
• Immune functions and recruitment of plasmacytoid dendritic cells in psoriasis

  2010cites this paper
• Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions

  2010cites this paper
• Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance

  2010cites this paper
• Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons

  2010cites this paper
• Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

  2009cites this paper